Discovery Value Fund Legend Biotech Corp Transaction History
Discovery Value Fund
- $195 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$429 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$288 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$255 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$220 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$193 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.43B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...